FBRX

Forte Biosciences, Inc.

Alert me on FBRX

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

After each filing

Jan 3 Buy Riley Antony A Insider

1 week

+31.5%S&P +1.1%

1 month

+42.0%S&P −0.2%

3 months

+16.0%S&P −3.9%

6 months

−8.8%S&P +9.0%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for FBRX

53 held · newest 553 held · newest 2

Loading the filings.

See all 53 filings for FBRX

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Signal history

No signal for this ticker yet. A signal is written when insider buying here scores one dot or more.

Stakes

Jun 30, 2026 Schedule 13G, amended

ORBIMED ADVISORS LLC: 6.2%, 1,264,980 shares

Jun 30, 2026 Schedule 13G, amended

Affinity Asset Advisors, LLC: 5.6%, 1,145,391 shares

Jun 30, 2026 Schedule 13G, amended

JANUS HENDERSON GROUP Ltd.: 9.3%, 1,894,076 shares

Jun 30, 2026 Schedule 13G, amended

Adage Capital Management, L.P.: 3.4%, 700,000 shares

Aug 4, 2026 Schedule 13G

Glazer Capital, LLC: 1.5%, 300,000 shares

Jul 31, 2026 Schedule 13G, amended

Alger Associates, Inc.: 4.6%, 935,514 shares

Jul 31, 2026 Schedule 13G, amended

JANUS HENDERSON GROUP Ltd.: 2.5%, 521,016 shares

Jun 30, 2026 Schedule 13G

BlackRock, Inc.: 5.9%, 1,204,632 shares

Jun 30, 2026 Schedule 13G, amended

Millennium Management LLC: 3.2%, 655,199 shares

Jun 30, 2026 Schedule 13G, amended

Federated Hermes, Inc.: 10.3%, 2,110,516 shares

Jun 4, 2026 Schedule 13G

Millennium Management LLC: 5.2%, 1,062,182 shares

Mar 31, 2026 Schedule 13G, amended

ORBIMED ADVISORS LLC: 4.3%, 884,230 shares

Mar 31, 2026 Schedule 13G, amended

Point72 Asset Management, L.P.: 0%, 0 shares

Mar 31, 2026 Schedule 13G

MPM BioImpact LLC: 7.2%, 1,000,682 shares

Mar 31, 2026 Schedule 13G, amended

Alger Associates, Inc.: 10.2%, 624,286 shares

Mar 31, 2026 Schedule 13G, amended

JANUS HENDERSON GROUP PLC: 10%, 1,387,178 shares

Mar 31, 2026 Schedule 13G, amended

Affinity Asset Advisors, LLC: 7.3%, 1,011,890 shares

Mar 31, 2026 Schedule 13G

Adage Capital Management, L.P.: 6.8%, 950,000 shares

Dec 31, 2025 Schedule 13G, amended

JANUS HENDERSON GROUP PLC: 11.4%, 1,425,785 shares

Jan 22, 2026 Schedule 13G, amended

Affinity Asset Advisors, LLC: 6.7%, 834,964 shares

Jan 12, 2026 Schedule 13G

Point72 Asset Management, L.P.: 6.3%, 792,976 shares

Jan 8, 2026 Schedule 13G, amended

Oliveira Steven Michael: 2.4%, 300,100 shares

Dec 17, 2025 Schedule 13G

Affinity Asset Advisors, LLC: 6.9%, 862,400 shares

Sep 30, 2025 Schedule 13G, amended

BVF GP HOLDINGS LLC: 0.5%, 60,523 shares

Sep 30, 2025 Schedule 13G, amended

Alger Associates, Inc.: 13.1%, 1,634,267 shares

Sep 30, 2025 Schedule 13G, amended

Federated Hermes, Inc.: 13.2%, 1,635,380 shares

Schedule 13D is filed within 5 business days of crossing 5 percent by an investor who may seek to influence the company. Schedule 13G is filed by a passive holder, and a large institution has up to 45 days after the quarter end.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

No lobbying reports on file.